Digestive Diseases and Sciences

, Volume 56, Issue 6, pp 1656–1662

Mechanism of Regulation of Na-H Exchanger in Inflammatory Bowel Disease: Role of TLR-4 Signaling Mechanism

Original Article

Abstract

Objective

We investigated the role of toll-like receptor-4 (TLR-4) signal transduction in the regulation of Na-H exchanger-1 isoform (NHE-1) in ulcerative colitis (UC).

Methods

Colonic biopsies from control and UC patients were selected from four groups: controls (group 1), untreated UC patients (group 2), UC patients treated with 5′-aminosalicylic acid (5′-ASA) plus steroid (group 3), and UC patients treated with 5′-ASA plus azathioprine (AZA) (group 4). Patients presenting with abdominal pain (n = 13) and a normal colon on endoscopy served as controls. NHE-1, TLR-4, MyD88, NFkB and actin protein levels were estimated using Western blot analysis and sodium pump activity (PNPase) by a spectrophotometeric method. Myeloperoxidase (MPO) activity and histologic evaluation confirmed inflammation.

Results

PNPase activity decreased significantly (P < 0.05) in the untreated UC patients as compared to the controls or treated UC groups 3 and 4. There was a significant decrease of NHE-1 and a significant increase (P < 0.05) of TLR-4, MyD88 and NFkB protein levels in the untreated UC or 5′-ASA plus steroid treated UC patients as compared to the controls. NHE-1, TLR-4, MyD88 and NFkB protein levels were not significantly different in 5′-ASA plus AZA treated biopsies as compared to controls. The level of actin remained unaltered. Inflammatory cells’ infiltration and MPO activity increased significantly in the untreated UC, but was significantly lower in the treated UC groups 3 and 4 (P < 0.05).

Conclusions

These findings suggest that NHE-1 in UC is regulated by NFkB induced through TLR-4 and MyD88 signaling mechanism. These findings identify TLR-4 as a putative therapeutic target for IBD.

Keywords

IBD Ulcerative colitis Crohn’s colitis Na+/H+ exchanger Sodium pump Myeloperoxidase 

References

  1. 1.
    Allgayer H, Kruis W, Paumgartner G, Wiebecke B, Brown L, Erdmann E. Inverse relationship between colonic [Na++K+]-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci. 1988;33:417–422.PubMedCrossRefGoogle Scholar
  2. 2.
    Siddique I, Hasan F, Khan I. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5’-aminosalicylate treatment. Scand J Gastroenterol. 2009;44:56–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Khan I, Siddique I, Al-Awadi FM, Mohan K. Role of Na+/H+ exchanger isoform-1 in human inflammatory bowel disease. Can J Gastroenterol. 2003;17:31–36.PubMedGoogle Scholar
  4. 4.
    Khan I, Collins SM. Altered expression of sodium pump isoforms in the inflamed intestine of Trichinella spiralis-infected rats. Am J Physiol. 1993;264:G1160–G1168.PubMedGoogle Scholar
  5. 5.
    Khan I. Molecular basis of altered contractility in experimental colitis: expression of L-type calcium channel. Dig Dis Sci. 1999;44:1525–1530.PubMedCrossRefGoogle Scholar
  6. 6.
    Al-Jarallah A, Oriowo MA, Khan I. Mechanism of reduced colonic contractility in experimental colitis: role of sarcoplasmic reticulum pump isoform-2. Mol Cell Biochem. 2007;298:169–178.PubMedCrossRefGoogle Scholar
  7. 7.
    Marzio L, Blennerhassett P, Chiverton S, Vermillion DL, Langer J, Collins SM. Altered smooth muscle function in worm-free gut regions of Trichinella-infected rats. Am J Physiol. 1990;259:G306–G313.PubMedGoogle Scholar
  8. 8.
    Khan I. Genetic diversity and pathogenic relevance of sodium hydrogen exchanger. In: McNamara AP, ed. Trends in RNA research. New York: Nova Science Press; 2006:191–223.Google Scholar
  9. 9.
    Fliegel L. Regulation of the Na[+]/H[+] exchanger in the healthy and diseased myocardium. Expert Opin Ther Targets. 2009;13:55–68.PubMedCrossRefGoogle Scholar
  10. 10.
    Maher MM, Gontarek JD, Bess RS, Donowitz M, Yeo CJ. The Na+/H+ exchange isoform NHE3 regulates basal canine ileal Na + absorption in vivo. Gastroenterology. 1997;112:174–183.PubMedCrossRefGoogle Scholar
  11. 11.
    Fallingborg J, Christensen LA, Jacobsen BA, Rasmussen SN. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig Dis Sci. 1993;38:1989–1993.PubMedCrossRefGoogle Scholar
  12. 12.
    Khan I, Al-Awadi FM, Abul H. Colitis-induced changes in the expression of the Na+/H+ exchanger isoform NHE-1. J Pharmacol Exp Ther. 1998;285:869–875.PubMedGoogle Scholar
  13. 13.
    Khan I, Ali M. Altered expression of the Na+/H+ exchanger isoform-3 in experimental colitis: effect of garlic. Mol Cell Biochem. 1999;200:77–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Rousseaux C, Lefebvre B, Dubuquoy L, et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med. 2005;201:1205–1215.PubMedCrossRefGoogle Scholar
  15. 15.
    Bultman E, Kuipers EJ, van der Woude CJ. Systematic review: steroid withdrawal in anti-TNF-treated patients with inflammatory bowel disease. Aliment Pharmacol Ther, 2010;32:313–323.Google Scholar
  16. 16.
    Thomas CW, Myhre GM, Tschumper R, et al. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines. J Pharmacol Exp Ther. 2005;312:537–545.PubMedCrossRefGoogle Scholar
  17. 17.
    Weersma RK, van Dullemen HM, Van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G. Review article: Inflammatory bowel disease and genetics. Aliment Pharmacol Ther. 2007;26:57–65.PubMedCrossRefGoogle Scholar
  18. 18.
    Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. In silico simulation of corticosteroids effect on an NFkB-dependent physicochemical model of systemic inflammation. PLoS One. 2009;4:e4706.PubMedCrossRefGoogle Scholar
  19. 19.
    Lubbad A, Oriowo MA, Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem. 2009;322:127–135.PubMedCrossRefGoogle Scholar
  20. 20.
    Sepúlveda SE, Beltrán CJ, Peralta A, et al. Inflammatory bowel diseases: an immunological approach. Rev Med Chil. 2008;136:367–375.PubMedGoogle Scholar
  21. 21.
    Fukata M, Abreu MT. TLR4 signaling in the intestine in health and disease. Biochem Soc Trans. 2007;35:1473–1478.PubMedCrossRefGoogle Scholar
  22. 22.
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature [Lond]. 1970;227:680–685.CrossRefGoogle Scholar
  23. 23.
    Khan I, Thomas N, Haridas S. Expression and sub cellular localization of the sodium hydrogen exchanger isoform-1 in rat tissues: a possible functional relevance. Mol Cell Biochem. 2001;219:153–161.PubMedCrossRefGoogle Scholar
  24. 24.
    Grover AK, Samson SE. Pig coronary artery smooth muscle: substrate and pH dependence of the two calcium pumps. Am J Physiol. 1986;251:C529–C534.PubMedGoogle Scholar
  25. 25.
    Leonard N, Bishop AE, Polak JM, Talbot IC. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol. 1998;5:750–753.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Medicine, Faculty of MedicineKuwait UniversitySafatKuwait
  2. 2.Department of Biochemistry, Faculty of MedicineKuwait UniversitySafatKuwait

Personalised recommendations